188 related articles for article (PubMed ID: 31242412)
21. Efficient Generation of Large-Fragment Knock-In Mouse Models Using 2-Cell (2C)-Homologous Recombination (HR)-CRISPR.
Gu B; Posfai E; Gertsenstein M; Rossant J
Curr Protoc Mouse Biol; 2020 Mar; 10(1):e67. PubMed ID: 31912993
[TBL] [Abstract][Full Text] [Related]
22. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
23. [Genome editing in plants directed by CRISPR/Cas ribonucleoprotein complexes].
Li X; Shi W; Geng LZ; Xu JP
Yi Chuan; 2020 Jun; 42(6):556-564. PubMed ID: 32694114
[TBL] [Abstract][Full Text] [Related]
24. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
25. Donor template delivery by recombinant adeno-associated virus for the production of knock-in mice.
Duddy G; Courtis K; Horwood J; Olsen J; Horsler H; Hodgson T; Varsani-Brown S; Abdullah A; Denti L; Lane H; Delaqua F; Janzen J; Strom M; Rosewell I; Crawley K; Davies B
BMC Biol; 2024 Feb; 22(1):26. PubMed ID: 38302906
[TBL] [Abstract][Full Text] [Related]
26. [Recent developments in enhancing the efficiency of CRISPR/Cas9- mediated knock-in in animals].
Li GL; Yang SX; Wu ZF; Zhang XW
Yi Chuan; 2020 Jul; 42(7):641-656. PubMed ID: 32694104
[TBL] [Abstract][Full Text] [Related]
27. Streamlined ex vivo and in vivo genome editing in mouse embryos using recombinant adeno-associated viruses.
Yoon Y; Wang D; Tai PWL; Riley J; Gao G; Rivera-Pérez JA
Nat Commun; 2018 Jan; 9(1):412. PubMed ID: 29379011
[TBL] [Abstract][Full Text] [Related]
28. Combination of the clustered regularly interspaced short palindromic repeats (CRISPR)-associated 9 technique with the piggybac transposon system for mouse in utero electroporation to study cortical development.
Cheng M; Jin X; Mu L; Wang F; Li W; Zhong X; Liu X; Shen W; Liu Y; Zhou Y
J Neurosci Res; 2016 Sep; 94(9):814-24. PubMed ID: 27317429
[TBL] [Abstract][Full Text] [Related]
29. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
30. Optimized CRISPR/Cas9-mediated in vivo genome engineering applicable to monitoring dynamics of endogenous proteins in the mouse neural tissues.
Matsuda T; Oinuma I
Sci Rep; 2019 Aug; 9(1):11309. PubMed ID: 31383899
[TBL] [Abstract][Full Text] [Related]
31. In Vivo AAV-CRISPR/Cas9-Mediated Gene Editing Ameliorates Atherosclerosis in Familial Hypercholesterolemia.
Zhao H; Li Y; He L; Pu W; Yu W; Li Y; Wu YT; Xu C; Wei Y; Ding Q; Song BL; Huang H; Zhou B
Circulation; 2020 Jan; 141(1):67-79. PubMed ID: 31779484
[TBL] [Abstract][Full Text] [Related]
32. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
33. A novel technique for large-fragment knock-in animal production without ex vivo handling of zygotes.
Abe M; Nakatsukasa E; Natsume R; Hamada S; Sakimura K; Watabe AM; Ohtsuka T
Sci Rep; 2023 Feb; 13(1):2245. PubMed ID: 36755180
[TBL] [Abstract][Full Text] [Related]
34. CRISPR-Cas9 knockin mice for genome editing and cancer modeling.
Platt RJ; Chen S; Zhou Y; Yim MJ; Swiech L; Kempton HR; Dahlman JE; Parnas O; Eisenhaure TM; Jovanovic M; Graham DB; Jhunjhunwala S; Heidenreich M; Xavier RJ; Langer R; Anderson DG; Hacohen N; Regev A; Feng G; Sharp PA; Zhang F
Cell; 2014 Oct; 159(2):440-55. PubMed ID: 25263330
[TBL] [Abstract][Full Text] [Related]
35. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
Bak RO; Porteus MH
Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
[TBL] [Abstract][Full Text] [Related]
36. CRISPR/Cas9 + AAV-mediated Intra-embryonic Gene Knocking in Mice.
Mizuno N; Mizutani E; Sato H; Kasai M; Nakauchi H; Yamaguchi T
Bio Protoc; 2019 Jul; 9(13):e3295. PubMed ID: 33654808
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells.
Cheng Q; Xia J; Wang K; Zhang Y; Chen Y; Zhong Q; Wang X; Wu Q
Ann Transl Med; 2022 Aug; 10(16):862. PubMed ID: 36111017
[TBL] [Abstract][Full Text] [Related]
38. One-step generation of modular CAR-T cells with AAV-Cpf1.
Dai X; Park JJ; Du Y; Kim HR; Wang G; Errami Y; Chen S
Nat Methods; 2019 Mar; 16(3):247-254. PubMed ID: 30804551
[TBL] [Abstract][Full Text] [Related]
39. Electroporation-Mediated Genome Editing of Livestock Zygotes.
Lin JC; Van Eenennaam AL
Front Genet; 2021; 12():648482. PubMed ID: 33927751
[TBL] [Abstract][Full Text] [Related]
40. Highly efficient CRISPR/HDR-mediated knock-in for mouse embryonic stem cells and zygotes.
Wang B; Li K; Wang A; Reiser M; Saunders T; Lockey RF; Wang JW
Biotechniques; 2015 Oct; 59(4):201-2, 204, 206-8. PubMed ID: 26458548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
